Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care. The study used a US health insurance claims database, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Amend, Kandace L., Turnbull, Bruce, Zhou, Li, Marks, Morgan A., Velicer, Christine, Saddier, Patricia, Seeger, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481146/
https://www.ncbi.nlm.nih.gov/pubmed/35714277
http://dx.doi.org/10.1080/21645515.2022.2073750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481146/
https://www.ncbi.nlm.nih.gov/pubmed/35714277
http://dx.doi.org/10.1080/21645515.2022.2073750

Ejemplares similares